SEATTLE, WA -- (Marketwired) -- 12/09/13 -- Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today released a statement from...
Television host and film and TV producer, Jack Osbourne, is helping to
raise awareness about multiple sclerosis (MS), through a new campaign
called You Don’t Know Jack About MS™. The online documentary
series, sponsored by...
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Takeda
Pharmaceutical Company Limited (Takeda) today announced the signing
earlier this year of an agreement in which Teva licensed to Takeda the
right to commercialize...
After a scathing staff review, Sanofi walked away from an FDA panel with mixed messages on its long-delayed multiple sclerosis drug, as agency advisers said the injection wasn't too risky to approve but took issue with the drugmaker's trial design.
SAN DIEGO (MedPage Today) -- Stimulating dendritic cells with interferon-gamma caused them to release exosomes that promoted neuronal myelination in vitro and in live rats, offering a potential therapy for advanced multiple sclerosis.
Oops! Unable to complete your request. Please refresh your browser.